These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25031744)

  • 1. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
    Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
    Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance.
    Costa WH; Rocha RM; Cunha IW; Guimaraes GC; Zequi Sde C
    Int Braz J Urol; 2012; 38(4):456-65. PubMed ID: 22951174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.
    Wang Z; Xu L; Chang Y; Zhou L; Fu H; Zhang W; Yang Y; Xu J
    Tumour Biol; 2016 Aug; 37(8):11127-34. PubMed ID: 26926076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
    Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
    Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear and cytosolic pS727-STAT3 levels correlate with overall survival of patients affected by clear cell renal cell carcinoma (ccRCC).
    Arévalo J; Lorente D; Trilla E; Salcedo MT; Morote J; Meseguer A
    Sci Rep; 2021 Mar; 11(1):6957. PubMed ID: 33772065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
    Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
    Lee C; Park JW; Suh JH; Moon KC
    Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.
    Chang Y; Xu L; An H; Fu Q; Chen L; Lin Z; Xu J
    Int J Clin Exp Pathol; 2015; 8(2):1594-603. PubMed ID: 25973044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
    Parker AS; Eckel-Passow JE; Serie D; Hilton T; Parasramka M; Joseph RW; Wu KJ; Cheville JC; Leibovich BC
    Eur Urol; 2014 Nov; 66(5):929-35. PubMed ID: 24388441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.
    Li L; Tang W; Wu X; Karnak D; Meng X; Thompson R; Hao X; Li Y; Qiao XT; Lin J; Fuchs J; Simeone DM; Chen ZN; Lawrence TS; Xu L
    Clin Cancer Res; 2013 Dec; 19(24):6703-15. PubMed ID: 24132924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC.
    Ma J; Li M; Chai J; Wang K; Li P; Liu Y; Zhao D; Xu J; Yu K; Yan Q; Guo S; Wang Z; Fan L
    Diagn Pathol; 2020 Mar; 15(1):28. PubMed ID: 32209138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
    Jung M; Lee C; Park JH; Moon KC
    Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
    Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
    Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin α7 is overexpressed and correlates with higher pathological grade, increased T stage, advanced TNM stage as well as worse survival in clear cell renal cell carcinoma patients: A retrospective study.
    Chen Y; Wang Y; Cai Z; Fan X; Zhang Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23034. PubMed ID: 31713264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).
    Abbas M; Steffens S; Bellut M; Eggers H; Großhennig A; Becker JU; Wegener G; Schrader AJ; Grünwald V; Ivanyi P
    Med Oncol; 2016 Jul; 33(7):80. PubMed ID: 27317388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endothelin 2 and localized clear cell renal cell carcinoma.
    Bot BM; Eckel-Passow JE; LeGrand SN; Hilton T; Cheville JC; Igel T; Parker AS
    Hum Pathol; 2012 Jun; 43(6):843-9. PubMed ID: 22047647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.